These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8045021)

  • 1. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis.
    Buffone GJ; Beck JR
    Clin Chem; 1994 Aug; 40(8):1631-6. PubMed ID: 8045021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.
    Baer DM; Simons JL; Staples RL; Rumore GJ; Morton CJ
    Am J Med; 1995 May; 98(5):464-8. PubMed ID: 7733125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians.
    Schmitt B; Golub RM; Green R
    Ann Intern Med; 2005 Oct; 143(7):522-36. PubMed ID: 16204165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.
    Adams PC; Gregor JC; Kertesz AE; Valberg LS
    Gastroenterology; 1995 Jul; 109(1):177-88. PubMed ID: 7797016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of screening for hereditary hemochromatosis.
    Phatak PD; Guzman G; Woll JE; Robeson A; Phelps CE
    Arch Intern Med; 1994 Apr; 154(7):769-76. PubMed ID: 8147681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients.
    Balan V; Baldus W; Fairbanks V; Michels V; Burritt M; Klee G
    Gastroenterology; 1994 Aug; 107(2):453-9. PubMed ID: 8039622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of population-based screening for phenotypic hemochromatosis in young men.
    Asberg A; Tretli S; Hveem K; Bjerve KS
    Scand J Gastroenterol; 2002 Oct; 37(10):1212-9. PubMed ID: 12408528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for hereditary HFE hemochromatosis].
    Deugnier Y; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1292-4. PubMed ID: 17544612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic hemochromatosis: importance of population screening?].
    Cartabellotta A; Montalto G
    Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis.
    El-Serag HB; Inadomi JM; Kowdley KV
    Ann Intern Med; 2000 Feb; 132(4):261-9. PubMed ID: 10681280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hereditary hemochromatosis in 16031 primary care patients.
    Phatak PD; Sham RL; Raubertas RF; Dunnigan K; O'Leary MT; Braggins C; Cappuccio JD
    Ann Intern Med; 1998 Dec; 129(11):954-61. PubMed ID: 9867748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers.
    Bassett ML; Leggett BA; Halliday JW; Webb S; Powell LW
    J Hepatol; 1997 Sep; 27(3):517-24. PubMed ID: 9314130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a workplace hemochromatosis screening program.
    Stave GM; Mignogna JJ; Powell GS; Hunt CM
    Am J Prev Med; 1999 May; 16(4):303-6. PubMed ID: 10493286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary hemochromatosis.
    Crownover BK; Covey CJ
    Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary hemochromatosis.
    Franchini M; Veneri D
    Hematology; 2005 Apr; 10(2):145-9. PubMed ID: 16019461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemochromatosis: should clinicians screen for this common disease?
    Russell LC
    J Am Acad Nurse Pract; 2000 Jul; 12(7):273-9. PubMed ID: 11930466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.